What are the recommended first-line anti-resorptive drugs for the treatment of osteoporosis according to the latest clinical guidelines?
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901263332933632 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | First-line anti-resorptive drugs for osteoporosis include bisphosphonates and denosumab, with some guidelines also recommending SERMs and romosozumab depending on specific patient needs. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18713437 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What are the recommended first-line anti-resorptive drugs for the treatment of osteoporosis according to the latest clinical guidelines? Tripdatabase osteoporosis anti-resorptive drugs clinical guidelines first-line treatment osteoporosis management First-line anti-resorptive drugs for osteoporosis include bisphosphonates and denosumab, with some guidelines also recommending SERMs and romosozumab depending on specific patient needs. |
| title | What are the recommended first-line anti-resorptive drugs for the treatment of osteoporosis according to the latest clinical guidelines? |
| topic | osteoporosis anti-resorptive drugs clinical guidelines first-line treatment osteoporosis management |
| url | https://doi.org/10.5281/zenodo.18713437 |